Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >
9/21/12

What Gene Mutations Matter in CLL

Researchers are discovering new genetic mutations in cancer cells at an ever more rapid pace. Some of these discoveries have immediate significance for a CLL patient's prognosis and treatment strategy while the significance of some other mutations is less clear. Renowned CLL expert, Dr. Stefan Stilgenbauer explains which of these genetic mutations are significant now and discusses why. He also explains how exciting, investigational treatments could vastly improve outcomes and reduce side effects for a broad group of CLL patients.

Get Email Updates:

Get updated automatically when new content about Chronic Lymphocytic Leukemia has been posted.
Privacy Policy
Chronic Lymphocytic Leukemia

Experts & Guests

Stephan Stilgenbauer, M.D. Stephan Stilgenbauer, M.D.
Associate Professor at the Department of Haematology, Oncology, Rheumatology and Infectious Diseases, University of Ulm
Dr. Stephan Stilgenbauer is Associate Professor in the Department of Hematology, Oncology, Rheumatology and Infectious Diseases at the University of Ulm, Germany. He received his medical training at Ruprecht-Karls Universität Heidelberg Medical School, Germany with electives in Hamilton, Canada; Jerusalem, Israel; Bath, UK and Cambridge, UK. He went on to complete his final year at the Baylor College of Medicine... more >

Transcript

Related Videos

Dr. Susan Leclair explains the meaning behind key tests about which CLL patients are curious.

Watch Now

Dr. Stephan Stilgenbauer, from the University of Ulm, explains evolving understanding of CLL sub-types from ASH 2011.

Watch Now

Dr. Susan O'Brien talks about the promise of therapy that may eventually replace chemotherapy treatment for some CLL patients

Watch Now